Loading...
Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis
New chemotherapeutic compounds are needed to combat multidrug-resistant Mycobacterium tuberculosis (Mtb), which remains a serious public-health challenge. Decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1 enzyme) has been characterized as an attractive therapeutic target to address this urgent dem...
Na minha lista:
| Udgivet i: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4942819/ https://ncbi.nlm.nih.gov/pubmed/27405961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep29717 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|